Ubie, Japanese Health-Tech Startup, Raises $26.2 Million In Series C, $59.8 Million In Total

Aug 22, 2022•almost 3 years ago

Amount Raised

$26.2 Million

Round Type

series c

JapanMedicalArtificial IntelligenceBiotechnologyHealth Care

Description

Ubie, Inc., a healthcare AI startup with the mission "To develop a healthcare guide for everyone," announced that it has raised $26.2 million (*1) in the 1st round of Series C funding. New investors in the round include Norinchukin Capital Co., Ltd., NVenture Capital Limited (wholly owned subsidiary of NEC Capital Solutions Limited), The Dai-ichi Life Insurance Company, Limited, and Egg FORWARD, Inc., while existing investors include SUZUKEN CO., LTD. To date, Ubie has raised $59.8 million (*2).

Company Information

Company

Ubie

Location

Japan

About

Ubie is a med tech startup founded in 2017 by doctors and engineers to guide patient to right treatment at the right time. Ubie provides AI medical interview system for hospitals and general practices, as well as a symptom-checker type application for users outside of the hospital. The product allows users to know the predicted disease and its right treatment in home and enable hospital to streamline the entire outpatient workflow supported by the AI engine. Adoption of our AI medical interview system (“Ubie AI-Monshin”) has grown rapidly since product launch two years ago, and is currently in use by hundreds of prestigious medical institutions across Japan. In addition to the medical institutions, Ubie collaborates with various stakeholders across wellness and life science sectors to develop an ideal health eco-system.

Related People

Funding Insights

Based on industry data

Tech investment trends

83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech